Caisse Des Depots ET Consignations Purchases Shares of 4,297 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Caisse Des Depots ET Consignations acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 4,297 shares of the company’s stock, valued at approximately $336,000.

Several other hedge funds have also modified their holdings of GEHC. Homestead Advisers Corp raised its stake in GE HealthCare Technologies by 43.2% during the fourth quarter. Homestead Advisers Corp now owns 513,100 shares of the company’s stock worth $40,114,000 after purchasing an additional 154,700 shares during the period. NEOS Investment Management LLC increased its holdings in shares of GE HealthCare Technologies by 23.9% during the 4th quarter. NEOS Investment Management LLC now owns 53,048 shares of the company’s stock worth $4,147,000 after buying an additional 10,219 shares during the last quarter. UniSuper Management Pty Ltd raised its position in shares of GE HealthCare Technologies by 34.5% in the 4th quarter. UniSuper Management Pty Ltd now owns 40,492 shares of the company’s stock worth $3,166,000 after buying an additional 10,379 shares during the period. JPMorgan Chase & Co. boosted its holdings in GE HealthCare Technologies by 53.5% in the fourth quarter. JPMorgan Chase & Co. now owns 3,428,586 shares of the company’s stock valued at $268,047,000 after acquiring an additional 1,194,983 shares during the last quarter. Finally, Elo Mutual Pension Insurance Co grew its position in GE HealthCare Technologies by 22.8% during the fourth quarter. Elo Mutual Pension Insurance Co now owns 47,008 shares of the company’s stock valued at $3,675,000 after acquiring an additional 8,729 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $81.66 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market cap of $37.34 billion, a price-to-earnings ratio of 18.86, a PEG ratio of 3.19 and a beta of 1.13. The business’s 50 day moving average is $86.79 and its two-hundred day moving average is $85.90.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.17%. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup increased their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.